Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.
Show more...
首席执行官
员工
219
国家
US
ISIN
US54948U1051
上市
0 Comments
分享你的想法
FAQ
Lucira Health 今天的股价是多少?▼
LHDX 当前价格为 $0.45 USD,在过去 24 小时内下跌了 -19.23%。在图表上更密切关注 Lucira Health 股票的表现。
Lucira Health 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Lucira Health 的股票以代码 LHDX 进行交易。